ALX Oncology Holdings Inc. (ALXO)

CIK 0001810182 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-06) · 99.1
Q1-2026 8-K (2026-05-08) · 99.1
Latest FY-2025 8-K (2026-02-27) · 99.1
Q3-2025 8-K (2025-11-07) · 99.1
Q2-2025 8-K (2025-08-12) · 99.1
Q1-2025 8-K (2025-05-08) · 99.1
FY-2024 8-K (2025-03-06) · 99.1
Q3-2024 8-K (2024-11-07) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1
Q1-2024 8-K (2024-05-09) · 99.1
FY-2023 8-K (2024-03-07) · 99.1
Q3-2023 8-K (2023-11-13) · 99.1  |  8-K (2023-10-04)

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Stockholders' Equity (deficit)
—
Consolidated Statements of Stockholders' Equity (deficit) (P)
—
Consolidated Statements of Stockholders' Equity (P)
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (P)
Notes
Acquisition of Assets and Ownership
—
Balance Sheet Components
Commitments and Contingencies
Cybersecurity Risk Management, Strategy, and Governance
—
Fair Value of Financial Instruments
Income Taxes
—
Insider Trading Arrangements
Leases
Net Loss Per Share
—
Net Loss Per Share Attributable To Common Stockholders
—
Organization
Pay Vs Performance Disclosure
Related-party Transactions
Segment Reporting
Significant Accounting Policies
Stock-based Compensation
Stockholders' Equity
Subsequent Events
Term Loan